39 related articles for article (PubMed ID: 28446541)
1. DIRC3 and near NABP1 genetic polymorphisms are associated laryngeal squamous cell carcinoma patient survival.
Shen Z; Ren W; Bai Y; Chen Z; Li J; Li B; Jin T; Cao P; Shao Y
Oncotarget; 2016 Nov; 7(48):79596-79604. PubMed ID: 27793000
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD105 but not of E-cadherin is associated with malignancy recurrence and disease-free interval in laryngeal cancer in men.
Zvrko E; Vuckovic L
Folia Histochem Cytobiol; 2023; 61(3):183-192. PubMed ID: 37787034
[TBL] [Abstract][Full Text] [Related]
3. Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis.
Chen J; Zhou J; Lu J; Xiong H; Shi X; Gong L
BMC Cancer; 2014 Jan; 14():15. PubMed ID: 24410905
[TBL] [Abstract][Full Text] [Related]
4. Value of routine follow-up for recurrence detection after treatment with curative intent for laryngeal squamous cell carcinoma.
van de Weerd C; Geurts SME; Vercoulen RJMT; van Veggel IHF; Brands MT; Marres HAM; Hermens RPMG; van Tol-Geerdink JJ; Kaanders JHAM; Takes RP
Eur J Surg Oncol; 2024 Jan; 50(1):107304. PubMed ID: 38043360
[TBL] [Abstract][Full Text] [Related]
5. DJ-1: a novel independent prognostic marker for survival in glottic squamous cell carcinoma.
Zhu XL; Wang ZF; Lei WB; Zhuang HW; Jiang HY; Wen WP
Cancer Sci; 2010 May; 101(5):1320-5. PubMed ID: 20345476
[TBL] [Abstract][Full Text] [Related]
6. BCCIP as a prognostic marker for radiotherapy of laryngeal cancer.
Rewari A; Lu H; Parikh R; Yang Q; Shen Z; Haffty BG
Radiother Oncol; 2009 Feb; 90(2):183-8. PubMed ID: 19046788
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of a panel of two biomarkers (E-cadherin and CD105) in laryngeal cancer.
Zvrko E; Vuckovic L; Radunovic M
Pol J Pathol; 2023; 74(4):225-231. PubMed ID: 38477084
[TBL] [Abstract][Full Text] [Related]
8. Filamin-A expression in laryngeal squamous cell carcinoma and its clinical significance.
Ouban A
Histol Histopathol; 2022 Feb; 37(2):125-136. PubMed ID: 34677823
[TBL] [Abstract][Full Text] [Related]
9. Expression of Connexins 37, 40 and 45, Pannexin 1 and Vimentin in Laryngeal Squamous Cell Carcinomas.
Mizdrak I; Mizdrak M; Racetin A; Bošković B; Benzon B; Durdov MG; Vukojević K; Filipović N
Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833374
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers in Laryngeal Squamous Cell Carcinoma: The Literature Review.
Verro B; Saraniti C; Carlisi D; Chiesa-Estomba C; Maniaci A; Lechien JR; Mayo M; Fakhry N; Lauricella M
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894464
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic, Prognostic, and Therapeutic Role for Angiogenesis Markers in Head and Neck Squamous Cell Carcinoma: A Narrative Review.
Alessandrini L; Astolfi L; Daloiso A; Sbaraglia M; Mondello T; Zanoletti E; Franz L; Marioni G
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445908
[TBL] [Abstract][Full Text] [Related]
12. Survivin-positive circulating tumor cells as a marker for metastasis of hepatocellular carcinoma.
Yu J; Wang Z; Zhang H; Wang Y; Li DQ
World J Gastroenterol; 2021 Nov; 27(43):7546-7562. PubMed ID: 34887648
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of survivin expression in patients with HNSCC: a systematic review and meta-analysis.
Zhou LQ; Hu Y; Xiao HJ
BMC Cancer; 2021 Apr; 21(1):424. PubMed ID: 33863308
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of CD105- and CD31-Assessed Microvessel Density in Paired Biopsies and Surgical Samples of Laryngeal Carcinoma.
Marioni G; Franz L; Ottaviano G; Contro G; Tealdo G; Carli A; Frigo AC; Nicolai P; Alessandrini L
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32722476
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy-Induced Changes in the Systemic Immune and Inflammation Parameters of Head and Neck Cancer Patients.
Balázs K; Kis E; Badie C; Bogdándi EN; Candéias S; Garcia LC; Dominczyk I; Frey B; Gaipl U; Jurányi Z; Kocsis ZS; Rutten EA; Sáfrány G; Widlak P; Lumniczky K
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31500214
[TBL] [Abstract][Full Text] [Related]
16. Nuclear survivin expression correlates with endoglin-assessed microvascularisation in laryngeal carcinoma.
Marioni G; Ottaviano G; Marchese-Ragona R; Fasanaro E; Tealdo G; Zanotti C; Randon B; Giacomelli L; Stellini E; Blandamura S
J Clin Pathol; 2017 Dec; 70(12):1033-1037. PubMed ID: 28446541
[TBL] [Abstract][Full Text] [Related]
17. A higher CD105-assessed microvessel density and worse prognosis in elderly patients with laryngeal carcinoma.
Marioni G; Staffieri A; Manzato E; Ralli G; Lionello M; Giacomelli L; Prosenikliev V; Marchese-Ragona R; Busnardo A; Bolzetta F; Blandamura S
Arch Otolaryngol Head Neck Surg; 2011 Feb; 137(2):175-80. PubMed ID: 21339405
[TBL] [Abstract][Full Text] [Related]
18. Relationship between anti-apoptotic proteins survivin and Bcl-2, and response to treatment in patients undergoing post-operative RT for laryngeal cancer: a pilot study.
Marioni G; Staffieri A; Lionello M; Tealdo G; Staffieri C; Giacomelli L; Friso ML; Stramare R; Ottaviano G; Blandamura S
J Oral Pathol Med; 2013 Apr; 42(4):339-44. PubMed ID: 23126236
[TBL] [Abstract][Full Text] [Related]
19. Neoangiogenesis in laryngeal carcinoma: angiogenin and CD105 expression is related to carcinoma recurrence rate and disease-free survival.
Marioni G; Marino F; Blandamura S; D'Alessandro E; Giacomelli L; Guzzardo V; Lionello M; De Filippis C; Staffieri A
Histopathology; 2010 Oct; 57(4):535-43. PubMed ID: 20955379
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
